Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds virus or component thereof
Patent
1995-06-07
1999-07-06
Scheiner, Laurie
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds virus or component thereof
4241391, 4241861, 4241891, 435 71, 435 693, 4352872, 435326, 435331, 435339, 435810, 5303871, 5303881, 5303883, 5303894, 5303911, 530808, G01N 3353, A61K 3929
Patent
active
059194545
ABSTRACT:
This invention relates to human or murine monoclonal antibodies specific for a peptide sequence of HCV E1, fragments of said monoclonal antibodies, hybridomas producing said monoclonal antibodies, in vitro diagnostic methods for detecting HCV E1-specific antigens in a biological sample, and diagnostic kits for detecting HCV E1-specific antigens in a biological sample.
REFERENCES:
patent: 5350671 (1994-09-01), Houghton et al.
Brechot Christian
Kremsdorf Dina
Porchon Colette
Institut Pasteur
Scheiner Laurie
LandOfFree
Nucleotide and peptide sequences of a hepatitis C virus isolate, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and peptide sequences of a hepatitis C virus isolate,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and peptide sequences of a hepatitis C virus isolate, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897250